Mapping the EQ-5D index by UPDRS and PDQ-8 in patients with Parkinson's disease

Health and Quality of Life Outcomes

Volumn 11, Issue 1, 2013, Pages

  Dams, Judith ^a   Klotsche, Jens ^b   Bornschein, Bernhard ^c   Reese, Jens P ^a   Balzer Geldsetzer, Monika ^a   Winter, Yaroslav ^a   Schrag, Anette ^d   Siderowf, Andrew ^e   Oertel, Wolfgang H ^a   Deuschl, Günther ^f   Siebert, Uwe ^c,g,h,i   Dodel, Richard ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b German Rheumatism Research Centre   (Germany)

^c UNIVERSITY FOR HEALTH SCIENCES   (Austria)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^e AVID RADIOPHARMACEUTICALS   (United States)

^f UNIVERSITY OF KIEL   (Germany)

^g Oncotyrol Center for Personalized Cancer Medicine   (Austria)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁱ HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

EuroQoL EQ 5D; Parkinson's disease; PDQ 8; Prediction; Quality of life; UPDRS

Indexed keywords

ADULT; AGED; ARTICLE; BAYES THEOREM; COST UTILITY ANALYSIS; EUROQOL 5 DIMENSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PARKINSON DISEASE; PARKINSON DISEASE QUESTIONNAIRE EIGHT DIMENSION; PREDICTION; QUALITY OF LIFE; UNIFIED PARKINSON DISEASE RATING SCALE;

FEMALE; HUMANS; MALE; PARKINSON DISEASE; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 84874669416     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-11-35     Document Type: Article

References (16)

1. Jenkinson C, Fitzpatrick R, Peto V. The Parkinson's disease questionnaire; User manual for the PDQ-39, PDQ-8 and PDQ summary index 1998, Oxford: Health Services Research Unit, Department of Public Health, University of Oxford.
2. The EuroQol Group EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 1990, 16(3):199-208. The EuroQol Group.
3. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine, vol 1 1996, New York, Oxford: Oxford University Press.
4. Institute for Quality and Efficiency in Health Care Allgemeine Methoden zur Bewertung von Verhältnissen zwischen Nutzen und Kosten http://www.iqwig.de/, Institute for Quality and Efficiency in Health Care.
5. International Society for Pharmacoeconomics and Outcomes Research Pharmacoeconomic guidelines around the world http://www.ispor.org, International Society for Pharmacoeconomics and Outcomes Research.
6. Spottke EA, Reuther M, Machat O, Bornschein B, von Campenhausen S, Berger K, Koehne-Volland R, Rieke J, Simonow A, Brandstaedter D, Siebert U, Oertel WH, Ulm G, Dodel R. Cost of illness and its predictors for Parkinson's disease in Germany. PharmacoEconomics 2005, 23(8):817-836.
7. Fahn S, Elton RL, . Members of the UPDRS Development Committee Unified Parkinson's disease rating scale. Recent developments in Parkinson's disease II 1987, 153-163. Florham Park, N.J: Macmillan Health Care Information, Fahn S, Marsden CD, Calne DB, Goldstein M, Members of the UPDRS Development Committee.
8. Greiner W, Claes C. Der EQ-5D der EuroQol Gruppe. Gesundheitsökonomische Evaluationen, vol. 4 2012, Graf v. d. Schulenburg J-M Berlin Heidelberg: Springer-Verlag, Schöffski O.
9. Greiner W, Weijnen T, Nieuwenhuizen M, Oppe S, de Charro F, . The Rotterdam Analysis Team A European EQ-5D VAS valuation set. The measurement and valuation of health status using EQ-5D - A European perspective - Evidence from the EuroQol BIOMED Reasearch Programme 2003, 103-142. Dordrecht: Kluwer Academic Publisher, Brooks R, Rabin R, Charro F, The Rotterdam Analysis Team.
10. Siderowf A, Ravina B, Glick HA. Preference-based quality-of-life in patients with Parkinson's disease. Neurology 2002, 59(1):103-108.
11. Schrag A, Selai C, Jahanshahi M, Quinn NP. The EQ-5D-a generic quality of life measure-is a useful instrument to measure quality of life in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2000, 69(1):67-73.
12. Cheung YB, Tan LC, Lau PN, Au WL, Luo N. Mapping the eight-item Parkinson's Disease Questionnaire (PDQ-8) to the EQ-5D utility index. Qual Life Res 2008, 17(9):1173-1181.
13. Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol 1999, 28(5):964-974.
14. Borchani H, Bielza C, Marti Nez-Marti NP, Larrañaga P. Markov blanket-based approach for learning multi-dimensional Bayesian network classifiers: an application to predict the European Quality of Life-5 Dimensions (EQ-5D) from the 39-item Parkinson's Disease Questionnaire (PDQ-39). J Biomed Inform 2012, 45(6):1175-1184.
15. Jia H, Zack MM, Moriarty DG, Fryback DG. Predicting the EuroQol Group's EQ-5D index from CDC's " Healthy Days" in a US sample. Med Decis Making 2011, 31(1):174-185.
16. Pregibon D. Goodness of link tests for generalized linear models. Applied Stats 1980, 29(1):15-24.